FDA approvals and PDUFA dates. Binary events for biotech; approval counts track the sector's productivity.
What to watch: Novel approvals per year; advisory committee votes. It arrives continuous, and the effect typically lasts days.
It sits in tier 4 — Stock and sector specific: Moves one company or one group, not the market. Any factor here becomes tier one if it gets large enough — a bank failure and a pandemic both started as somebody's sector news.
Its neighbourhood
Everything this entry connects to directly. Click any point to follow it.
Sectors it moves most
Also in Corporate actions and stock-specific events
- Individual earnings reports and guidance
- Pre-announcements and profit warnings
- Mergers and acquisitions
- IPOs, lockup expirations, and secondaries
- Share issuance and dilution
- Insider buying and selling
- Activist investors and 13D filings
- 13F holdings disclosures
- Analyst upgrades, downgrades, and price targets
- Short-seller reports and accounting questions
- Management and board changes
- Product launches, trial results, and approvals
- Litigation, settlements, and product liability
- Corporate credit rating changes
- Dividend cuts, initiations, and special dividends
- Stock splits
- Index inclusion and deletion
- IPO window and public-market shrinkage
- Private equity exit backlog and marks